Publicaciones en las que colabora con Maria Garcia Bravo (13)

2016

  1. Insulin receptor isoform A ameliorates long-term glucose intolerance in diabetic mice

    DMM Disease Models and Mechanisms, Vol. 9, Núm. 11, pp. 1271-1281

2010

  1. Smoking but not homozygosity for CYP1A2 g-163A allelic variant leads to earlier disease onset in patients with sporadic porphyria cutanea tarda

    Experimental Dermatology

2009

  1. Bone marrow-derived cells promote liver regeneration in mice with erythropoietic Protoporphyria

    Transplantation, Vol. 88, Núm. 12, pp. 1332-1340

  2. Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: Potential novel players in the progression of liver injury

    Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 29-37

  3. Identification and characterization of HMBS gene mutations in Spanish patients with acute intermittent porphyria

    Cellular and Molecular Biology, Vol. 55, Núm. 2, pp. 55-63

  4. Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria

    Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 38-44

2008

  1. Bone marrow transplantation into hemochromatotic mice decreases hepatic and duodenal iron overload

    International Journal of Biochemistry and Cell Biology, Vol. 40, Núm. 1, pp. 135-146

2007

  1. Molecular heterogeneity of familial porphyria cutanea tarda in Spain: Characterization of 10 novel mutations in the UROD gene

    British Journal of Dermatology, Vol. 157, Núm. 3, pp. 501-507

2005

  1. Effects of repeated administration with CP-55,940, a cannabinoid CB 1 receptor agonist on the metabolism of the hepatic heme

    International Journal of Biochemistry and Cell Biology, Vol. 37, Núm. 8, pp. 1620-1625

  2. Increased mitochondrial respiratory chain enzyme activities correlate with minor extent of liver damage in mice suffering from erythropoietic protoporphyria

    Experimental Dermatology, Vol. 14, Núm. 1, pp. 26-33

2004

  1. Hemoglobin content is increased in the human erythroleukemia K562 cell line by a 56.2-kD peptide from uremic plasma

    American Journal of Nephrology, Vol. 24, Núm. 2, pp. 230-234

  2. Volatile anaesthetics induce biochemical alterations in the heme pathway in a B-lymphocyte cell line established from hepatoerythropoietic porphyria patients (LBHEP) and in mice inoculated with LBHEP cells

    International Journal of Biochemistry and Cell Biology, Vol. 36, Núm. 2, pp. 216-222

2002

  1. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients.

    Cellular and molecular biology (Noisy-le-Grand, France), Vol. 48, Núm. 8, pp. 845-852